SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Letouzé, Eric ^a   Rosati, Roberto ^b,c   Komechen, Heloisa ^b,c   Doghman, Mabrouka ^c,d,e   Marisa, Laetitia ^a   Flück, Christa ^f   De Krijger, Ronald R ^g   Van Noesel, Max M ^g   Mas, Jean Christophe ^h   Pianovski, Mara A D ⁱ   Zambetti, Gerard P ^j   Figueiredo, Bonald C ^b,c   Lalli, Enzo ^c,d,e  

^a Cartes d'Identité des Tumeurs Program Ligue Nationale Contre le Cancer   (France)

^b INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^c CNRS   (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITÉ CÔTE D'AZUR   (France)

^f UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX TUMOR; ARTICLE; BCL2L1 GENE; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CHILD; CHROMOSOME 17; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC CODE; HAPLOTYPE; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; INFANT; KIT GENE; LINC00290 GENE; MALE; MCL1 GENE; MDM2 GENE; ONCOGENE; ONCOGENE MYC; PDGFRA GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; RB1 GENE; RPH3AL GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; AGE OF ONSET; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROARRAY ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 84863574093     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1184     Document Type: Article

References (40)

1. Wilkin F, Gagné N, Paquette J, Oligny LL, Deal C 2000 Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. J Clin Endocrinol Metab 85:2048-2056 (Pubitemid 32269319)
2. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, Marques R, Pianovski MA, Lacerda L, Cristofani LM, Jenkins J, Rodriguez-Galindo C, Ribeiro RC 2004 Clinical and outcome characteristics of childhood with adrenocortical tumors. An analysis of 254 cases from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 22:838-845 (Pubitemid 41103595)
3. West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R, Zambetti GP 2007 Gene expression profiling of childhood adrenocortical tumors. Cancer Res 67:600-608 (Pubitemid 46192198)
4. Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W,Peralta-Del ValleMH,Figueiredo BC, Zambetti GP, LalliE2010 Regulation of IGF-mTOR signalling by miRNA in childhood adrenocortical tumors. Cancer Res 70:4666-4675
5. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, CatI, Stratakis CA, Sandrini R 2001 An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98:9330-9335 (Pubitemid 32743916)
6. Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendonça BB, Latronico AC 2004 Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol 48:647-650
7. Garritano S, Gemignani F, Palmero EI, Olivier M, Martel-Planche G, Le Calvez-Kelm F, Brugiéres L, Vargas FR, Brentani RR, Ashton-Prolla P, Landi S, Tavtigian SV, Hainaut P, AchatzMI2010 Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum Mutat 31:143-150
8. Herrmann LJ, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S 2012 TP53 germline mutations in adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab 97:E476-E485
9. Custodio G, Taques GR, Figueiredo BC, Gugelmin ES, Oliveira Figueiredo MM, Watanabe F, Pontarolo R, Lalli E, Torres LF 2011 Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in Southern Brazil. PLoS ONE 6:e18015
10. Assumpção JG, Seidinger AL, Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA 2008 Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8:357
11. Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P 2007 The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 245:96-102 (Pubitemid 44959345)
12. Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM, Birch JM 1999 Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65:995-1006 (Pubitemid 30462956)
13. Rosati R, Cerrato F, Doghman M, PianovskiMA,Parise GA, Custó- dio G, Zambetti GP, Ribeiro RC, Riccio A, Figueiredo BC, Lalli E 2008 High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression is not associated with clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Cancer Genet Cytogenet 186:19-24
14. Popova T, Manié E, Stoppa-Lyonnet D, Rigaill G, Barillot E, Stern MH 2009 Genome alteration print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol 10:R128
15. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR 2007 Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012
16. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M 2010 The landscape of somatic copy-number alteration across human cancers. Nature 463:899-905
17. Smith JS, Tachibana I, Allen C, Chiappa SA, Lee HK, McIver B, Jenkins RB, Raffel C 1999 Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus. Genomics 59:97-101 (Pubitemid 29339878)
18. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG, Kang Y 2009 MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15:9-20
19. Hanahan D, Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144:646-674
20. Weksberg R, Smith AC, Squire J, Sadowski P 2003 Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12:R61-R68 (Pubitemid 36442955)
21. Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ 1997 Altered cell differentiation and proliferation in mice lacking p57(KIP2) indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158 (Pubitemid 27209424)
22. Fletcher JA 2004 Role of KIT and platelet-derived growth factor receptors as oncoproteins. Semin Oncol 31(2 Suppl 6):4-11 (Pubitemid 38879416)
23. Adhikary S, EilersM2005 Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645 (Pubitemid 41081267)
24. Yamasaki L 2003 Role of theRBtumor suppressor in cancer. Cancer Treat Res 115:209-239
25. Figueiredo BC, Stratakis CA, Sandrini R, DeLacerda L, Pianovsky MA, Giatzakis C, Young HM, Haddad BR 1999 Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 84:1116-1121 (Pubitemid 29138252)
26. James LA, Kelsey AM, Birch JM, Varley JM 1999 Highly consistent genetic alterations in childhood adrenocortical tumors detected by comparative genomic hybridization. Br J Cancer 81:300-304 (Pubitemid 29423709)
27. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P 2000 Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145-152 (Pubitemid 30246992)
28. Zhao J, Roth J, Bode-Lesniewska B, Pfaltz M, Heitz PU, Komminoth P 2002 Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer 34:48-57 (Pubitemid 34260596)
29. Barreau O, de Reynies A, Wilmot-Roussel H, Guillaud-Bataille M, Auzan C, René-Corail F, Tissier F, Dousset B, Bertagna X, Bertherat J, Clauser E, Assié G 2012 Clinical and pathophysiological Implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach. J Clin Endocrinol Metab 97:E301-E311
30. Lalli E 2010 Adrenocortical development and cancer: focus on SF-1. J Mol Endocrinol 44:301-307
31. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC, Zambetti G, DeLacerda L, Rodrigues GA, Haddad BR 2005 Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab 90:615-619 (Pubitemid 40279170)
32. Pianovski MA, Cavalli LR, Figueiredo BC, Santos SC, Doghman M, Ribeiro RC, Oliveira AG, Michalkiewicz E, Rodrigues GA, Zambetti G, Haddad BR, Lalli E 2006 SF-1 overexpression in childhood adrenocortical tumors. Eur J Cancer 42:1040-1043
33. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, Virolle V, Barbry P, Zambetti GP, Figueiredo BC, Heckert LL, Lalli E 2007 Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21:2968-2987 (Pubitemid 350223508)
34. Gotoh A, Broxmeyer HE 1997 The function of BCR/ABL and related proto-oncogenes. Curr Opin Hematol 4:3-11 (Pubitemid 27076433)
35. Palomero T, Ferrando A 2008 Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res 14:5314-5317
36. Kabe Y, Goto M, Shima D, Imai T, Wada T, Morohashi K, Shirakawa M, Hirose S, Handa H 1999 The role of human MBF1 as a transcriptional coactivator. J Biol Chem 274:34196-34202 (Pubitemid 129511757)
37. Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L 2010 Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 20:1482-1492
38. Stephan EA, Chung TH, Grant CS, Kim S, Von Hoff DD, Trent JM, Demeure MJ 2008 Adrenocortical carcinoma survival rates correlated to genomic copy number variants. Mol Cancer Ther 7:425-431 (Pubitemid 351302536)
39. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767 (Pubitemid 32896498)
40. Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D 2008 Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci USA 105:11264-11269